{"id":453620,"date":"2021-03-09T08:04:11","date_gmt":"2021-03-09T13:04:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=453620"},"modified":"2021-03-09T08:04:11","modified_gmt":"2021-03-09T13:04:11","slug":"zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/","title":{"rendered":"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h2 class=\"xn-hedline\">Funds to be used for unique back pain solution clinical studies.<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>MISGAV, <span class=\"xn-location\">Israel<\/span>, <span class=\"xn-chron\">March 9, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0<a target=\"_blank\" href=\"https:\/\/www.zygofix.com\/\" rel=\"nofollow noopener noreferrer\">ZygoFix,<\/a> a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading <span class=\"xn-location\">Israel<\/span>&#8211; and <span class=\"xn-location\">Singapore<\/span>-based investment group focused on high-growth medical and agrifood technologies, announced it has completed <span class=\"xn-money\">$2 million<\/span> round for its alternative solution to spinal fusion for sufferers of severe back pain. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1452573\/zLOCK_Implant.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1452573\/zLOCK_Implant.jpg\" title=\"Illustration of placement of the zLOCK implant in the spinal joints\" alt=\"Illustration of placement of the zLOCK implant in the spinal joints\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The funding round was led by Agriline (a trust of which Vincent Tchenguiz is a discretionary beneficiary), and Trendlines.\u00a0 Additional private investors and the Israel Innovation Authority also provided funding. The investment will be used to conduct further clinical studies, enhance the system implant and tools, and for regulatory clearance.<\/p>\n<p>ZygoFix&#8217;s zLOCK\u2122 is a miniature screwless implant that provides spinal stability and fusion. zLOCK\u2122 is the least invasive, simplest fusion option; it replaces complex screw stabilization, the current gold-standard used in such procedures. The ZygoFix zLOCK implant&#8217;s patented bendable features enable adjustment to specific joints&#8217; shapes during insertion. <\/p>\n<p>ZygoFix&#8217;s first clinical case in <span class=\"xn-location\">Israel<\/span> was performed by Dr. <span class=\"xn-person\">Lior Merom<\/span> at the Rambam Health Care Campus. The surgery included laminotomy and facet stabilization using two zLOCK implants for the treatment of back pain (facet arthritis) and spinal nerve compression (foraminal stenosis). The surgery was completed successfully with placement of the zLOCKs taking less than 30 minutes in total.<\/p>\n<p>Dr. Merom commented: &#8220;The simple and very low risk placement of the zLOCKs make it an attractive stabilization solution for suitable indications. We look forward to collecting more data as the study progresses.&#8221;<\/p>\n<p>This case opens the Israeli clinical study site, following the ongoing study in <span class=\"xn-location\">Hungary<\/span> which began in 2018. The ongoing study in <span class=\"xn-location\">Hungary<\/span> has demonstrated meaningful and sustained reduction in pain and increase in quality of life for patients, all with a minimally invasive, simple and short procedure.<\/p>\n<p>ZygoFix CEO <span class=\"xn-person\">Ofer Levy<\/span> commented, &#8220;Our technology rethinks spinal stability. We leverage the natural anatomical structure of the spine and insert the zLOCK implant which locks the motion in the joint.<\/p>\n<p>&#8220;We are very satisfied with this first case in <span class=\"xn-location\">Israel<\/span> as zLOCK adds a new treatment option to the surgeon&#8217;s toolbox. Its unique ability to perform internal facet fixation with a minimally invasive procedure enables us to treat pathologies in a simple manner, that were too complex and invasive to treat otherwise.&#8221;<\/p>\n<p>\n        <b>About ZygoFix<\/b>\n      <\/p>\n<p>ZygoFix was founded in 2017 by Prof. <span class=\"xn-person\">Yizhar Floman<\/span> and <span class=\"xn-person\">Uri Arnin<\/span>, experienced serial entrepreneurs in the spine industry (co-founders of ApiFix, acquired in <span class=\"xn-chron\">April 2020<\/span> by OrthoPediatrics Corp). \u00a0ZygoFix and ApiFix, both established in the Trendlines Group&#8217;s incubator, received initial investment from Trendlines and further funding from the Israel Innovation Authority.<\/p>\n<p>Contact information: <br \/><span class=\"xn-person\">Ofer Levy<\/span>, CEO ZygoFix <br \/><a target=\"_blank\" href=\"mailto:ofer@zygofix.com\" rel=\"nofollow noopener noreferrer\">ofer@zygofix.com<\/a><br \/>+972-522-664-981<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN03355&amp;sd=2021-03-09\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel-301243119.html\">http:\/\/www.prnewswire.com\/news-releases\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel-301243119.html<\/a><\/p>\n<p>SOURCE  ZygoFix<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN03355&amp;Transmission_Id=202103090800PR_NEWS_USPR_____LN03355&amp;DateId=20210309\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Funds to be used for unique back pain solution clinical studies. PR Newswire MISGAV, Israel, March 9, 2021 \/PRNewswire\/ &#8212;\u00a0ZygoFix, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading Israel&#8211; and Singapore-based investment group focused on high-growth medical and agrifood technologies, announced it has completed $2 million round for its alternative solution to spinal fusion for sufferers of severe back pain. The funding round was led by Agriline (a trust of which Vincent Tchenguiz is a discretionary beneficiary), and Trendlines.\u00a0 Additional private investors and the Israel Innovation Authority also provided funding. The investment will be used to conduct further clinical studies, enhance the system implant and tools, and for regulatory clearance. ZygoFix&#8217;s zLOCK\u2122 is a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-453620","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Funds to be used for unique back pain solution clinical studies. PR Newswire MISGAV, Israel, March 9, 2021 \/PRNewswire\/ &#8212;\u00a0ZygoFix, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading Israel&#8211; and Singapore-based investment group focused on high-growth medical and agrifood technologies, announced it has completed $2 million round for its alternative solution to spinal fusion for sufferers of severe back pain. The funding round was led by Agriline (a trust of which Vincent Tchenguiz is a discretionary beneficiary), and Trendlines.\u00a0 Additional private investors and the Israel Innovation Authority also provided funding. The investment will be used to conduct further clinical studies, enhance the system implant and tools, and for regulatory clearance. ZygoFix&#8217;s zLOCK\u2122 is a &hellip; Continue reading &quot;ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-09T13:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1452573\/zLOCK_Implant.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel\",\"datePublished\":\"2021-03-09T13:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/\"},\"wordCount\":476,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1452573\\\/zLOCK_Implant.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/\",\"name\":\"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1452573\\\/zLOCK_Implant.jpg\",\"datePublished\":\"2021-03-09T13:04:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1452573\\\/zLOCK_Implant.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1452573\\\/zLOCK_Implant.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/","og_locale":"en_US","og_type":"article","og_title":"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel - Market Newsdesk","og_description":"Funds to be used for unique back pain solution clinical studies. PR Newswire MISGAV, Israel, March 9, 2021 \/PRNewswire\/ &#8212;\u00a0ZygoFix, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading Israel&#8211; and Singapore-based investment group focused on high-growth medical and agrifood technologies, announced it has completed $2 million round for its alternative solution to spinal fusion for sufferers of severe back pain. The funding round was led by Agriline (a trust of which Vincent Tchenguiz is a discretionary beneficiary), and Trendlines.\u00a0 Additional private investors and the Israel Innovation Authority also provided funding. The investment will be used to conduct further clinical studies, enhance the system implant and tools, and for regulatory clearance. ZygoFix&#8217;s zLOCK\u2122 is a &hellip; Continue reading \"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-09T13:04:11+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1452573\/zLOCK_Implant.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel","datePublished":"2021-03-09T13:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/"},"wordCount":476,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1452573\/zLOCK_Implant.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/","name":"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1452573\/zLOCK_Implant.jpg","datePublished":"2021-03-09T13:04:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1452573\/zLOCK_Implant.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1452573\/zLOCK_Implant.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zygofix-completes-2-million-round-and-launches-a-new-clinical-study-in-israel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/453620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=453620"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/453620\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=453620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=453620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=453620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}